<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02656667</url>
  </required_header>
  <id_info>
    <org_study_id>ESNM (RB 15.058)</org_study_id>
    <nct_id>NCT02656667</nct_id>
  </id_info>
  <brief_title>Effect of Neuromuscular Electrical Stimulation Versus Cycle Ergometer Training in a Pulmonary Rehabilitation Program</brief_title>
  <acronym>ESNM</acronym>
  <official_title>Effect of Neuromuscular Electrical Stimulation Versus Cycle Ergometer Training in a Pulmonary Rehabilitation Program</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Brest</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Brest</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate the effectiveness of quadriceps strengthening with
      neuromuscular electrical stimulation versus cycle ergometer as part of pulmonary
      rehabilitation program , in patients with severe or very severe COPD , according to GOLD with
      BODE index ≥ 5 .
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It's a prospective ,multicentre,randomised, single-blind study which compare the
      effectiveness of quadriceps strengthening with neuromuscular electrical stimulation versus
      cycle ergometer training as part of pulmonary rehabilitation program.

      The program lasts from 3 to 4 weeks. 102 patients will included, diagnosed with COPD stages
      GOLD III and IV, and BODE index ≥ 5.

      The commun program: training protocol performed on treadmill,quadriceps resistance
      training,patient therapeutic education,collective gymnastics,relaxation, session
      psychological care, smoking cessation program and nutritional management if necessary.

      The primary criterion is the one minute sit to stand test.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 8, 2016</start_date>
  <completion_date type="Actual">March 21, 2019</completion_date>
  <primary_completion_date type="Actual">March 21, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>functional capacity of the lower limb muscles</measure>
    <time_frame>21 - 4 days / +7 days</time_frame>
    <description>Measure of the functional capacity of the lower limb muscles with the &quot;1 minute Sit To Stand Test &quot;</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Maximal isometric voluntary quadriceps strength assessment</measure>
    <time_frame>21 - 4 days / +7 days</time_frame>
    <description>Quadriceps strength assessment with handheld dynamometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>isometric voluntary quadriceps endurance assessment</measure>
    <time_frame>21 - 4 days / +7 days</time_frame>
    <description>Measure of isometric voluntary quadriceps endurance assessment with handheld dynamometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>assessment of exercise capacity</measure>
    <time_frame>21 - 4 days / +7 days</time_frame>
    <description>Six minute walking test for assessing exercise capacity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life Assessment</measure>
    <time_frame>21 - 4 days / +7 days</time_frame>
    <description>COPD assessment test for assessing quality of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dyspnea Assessment with Borg scale</measure>
    <time_frame>21 - 4 days / +7 days</time_frame>
    <description>Measure of dyspnea with Borg scale at the end of the six minute walking test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dyspnea Assessment with MRC Scale</measure>
    <time_frame>21 - 4 days / +7 days</time_frame>
    <description>Measure of dyspnea with Medical Research Council Dyspnea Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dyspnea Assessment with Dyspnea 12 questionnary</measure>
    <time_frame>21 - 4 days / +7 days</time_frame>
    <description>Measure of dyspnea with Dyspnea 12 questionnary</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inspiratory capacity (in litres) by spirometry</measure>
    <time_frame>21 - 4 days / +7 days</time_frame>
    <description>Measure of inspiratory capacity (in litres) by spirometry</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">102</enrollment>
  <condition>COPD</condition>
  <arm_group>
    <arm_group_label>neuromuscular electrical stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>conventional pulmonary rehabilitation including exercise training on treadmill and neuromuscular electrical stimulation with a medical device for quadriceps muscle strengthening</description>
  </arm_group>
  <arm_group>
    <arm_group_label>cycle ergometer training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>conventional pulmonary rehabilitation including exercise training on treadmill and quadriceps strenghthening on cycle-ergometer</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>neuromuscular electrical stimulation</intervention_name>
    <description>quadriceps strenghthening with neuromuscular electrical stimulation (medical device)</description>
    <arm_group_label>neuromuscular electrical stimulation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>cycle ergometer training</intervention_name>
    <description>quadriceps strenghthening with cycle ergometer training</description>
    <arm_group_label>cycle ergometer training</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Conventional pulmonary rehabilitation</intervention_name>
    <description>excercise training on treadmill</description>
    <arm_group_label>cycle ergometer training</arm_group_label>
    <arm_group_label>neuromuscular electrical stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with COPD stage 3 or 4, with BODE index ≥ 5

          -  Hospitalized in the pulmonary rehabilitation unit in the hospital of Morlaix or in the
             center &quot;Les Acacias&quot; of briançon, with a 3 at 4 weeks pulmonary rehabilitation course;

        Exclusion Criteria:

          -  FEV ≥ 50%

          -  Pneumonectomy, Lobectomy less than 6 months

          -  Contraindications to muscle electrostimulation quadriceps

          -  Absence of written consent

          -  Inability to follow the respiratory rehabilitation program in its entirety

          -  People equipped with electronic devices such as pacemakers and intracardiac
             defibrillators

          -  Skin lesions and infectious foci on the electrode placement area.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Francis Couturaud, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Brest</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre des maladies respiratoires et allergiques - Les Acacias</name>
      <address>
        <city>Briançon</city>
        <zip>05107</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH de Morlaix</name>
      <address>
        <city>Morlaix</city>
        <zip>29672</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>January 6, 2016</study_first_submitted>
  <study_first_submitted_qc>January 13, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 15, 2016</study_first_posted>
  <last_update_submitted>April 3, 2019</last_update_submitted>
  <last_update_submitted_qc>April 3, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 4, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>COPD pulmonary rehabilitation</keyword>
  <keyword>neuromuscular electrical stimulation</keyword>
  <keyword>sit to stand test COPD</keyword>
  <keyword>quadriceps strengthening</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <study_docs>
    <study_doc>
      <doc_id>22116795</doc_id>
      <doc_type>Clinical Study Report</doc_type>
      <doc_url>http://www.ncbi.nlm.nih.gov/pubmed</doc_url>
      <doc_comment>Vivodtzev I, Debigaré R, Gagnon P, and al. Vivodtzev I, Debigaré R, Gagnon P, Mainguy V, Saey D, Dubé A, Paré MÈ, Bélanger M, Maltais F. Functional and muscular effects of neuromuscular electrical stimulation in patients with severe COPD: a randomized clinical trial. Chest. 2012 Mar;141(3):716-25.</doc_comment>
    </study_doc>
    <study_doc>
      <doc_id>24418570</doc_id>
      <doc_type>Clinical Study Report</doc_type>
      <doc_url>http://www.ncbi.nlm.nih.gov/pubmed</doc_url>
      <doc_comment>Vieira PJ, Chiappa AM, Cipriano G Jr, Umpierre D, Arena R, Chiappa GR. Neuromuscular electrical stimulation improves clinical and physiological function in COPD patients.Respir Med. 2014 Apr;108(4):609-20.</doc_comment>
    </study_doc>
    <study_doc>
      <doc_id>23440837</doc_id>
      <doc_type>Clinical Study Report</doc_type>
      <doc_url>http://www.ncbi.nlm.nih.gov/pubmed</doc_url>
      <doc_comment>Maddocks M, Gao W, Higginson IJ, Wilcock A.Neuromuscular electrical stimulation for muscle weakness in adults with advanced disease. Cochrane Database Syst Rev. 2013 Jan 31;1.</doc_comment>
    </study_doc>
    <study_doc>
      <doc_id>16806873</doc_id>
      <doc_type>Clinical Study Report</doc_type>
      <doc_url>http://www.ncbi.nlm.nih.gov/pubmed</doc_url>
      <doc_comment>Ozalevli S, Ozden A, Itil O, Akkoclu A. Comparison of the Sit-to-Stand Test with 6 min walk test in patients with chronic obstructive pulmonary disease. Respir Med 2007;101(2):286-93.</doc_comment>
    </study_doc>
  </study_docs>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

